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We have studied the effects of long-term tetracycline 
and erythromycin admi11istration on the fecal flora of 
patients and their relatives. Tetracycline administra-
tion selects for multiply antibiotic-resistant organisms 
in both patients and rehl.tives. Erythromycin exerts no 
such selection pressure. The mechanisms by which this 
may occur are discussed. 
Antibiotics are effective therapy for the majority of patients 
with acne vulgaris, and theY are presc ribed for prolonged pe-
riods by dermatologists and general practitioners for this pur-
pose. Tetracyclines have been used for many years and are 
known to be effective and safe (1,2] . 
Erythromycin is also an effective antibiotic in this disease 
and is widely prescribed [3]. Studies of acne patients receiving 
tetracycline [ 4,5] have demonstrated rapid acquisition of tet-
racycline resistance by the bowel flora even while taking the 
antibiotic in low dosage; in some patients the resistant orga-
nisms may persist for severf:ll months [5,6). 
Prescribing habits have been held responsible for the pool of 
tetracycline-resistant organisms seen in the community (7]; as 
prescribers of large quantities of tetracycline, we felt it impor-
tant to assess the effect of tetracycline administration on the 
aerobic bowel flora of acne patients. It has a lso been reported 
that a husband and wife mf:lY share identical bowel organisms 
(8] and for this reason we hfive examined not only our patients 
but also their immediate relatives. In addition, we have com-
pared our tetracycline-taking group with patients taking eryth-
romycin and with their relatives. Erythromycin is a drug which 
would be expected to reduce the aerobic coliform flora but not 
to select for resistant organisms (9). 
MATERIALS AND METHODS 
Patients 
Eleven families comprising 26 people were studied. Six patients took 
erythromcyin; 5 tetracycline. 'fhe dosage was 500 mg/day during the 
treatment period. None of the patients nor their relatives had taken an 
antibiotic for at least 1 year. None of the relatives received antibiotics 
during the period of the assessrfient. 
The patients were aged 15- 24 years (mean 17.6 years). There were 
7 women and 4 men. The 15 relatives comprised 1 grandparent, 11 
parents, 1 sibling, and 2 spouses. All the relatives formed part of the 
same household as the patient. 
Methods 
Stool samples were obtained before therapy commenced and at 
monthly intervals thereafter fof periods between 5 and 14 months. 
One gram of feces was emulsified in 4.0 ml peptone water and 0.1 
ml of a tenfold dilution of this ,;uspension was pipetted to MacConkey 
agar and to MacCo nkey agar containing the following antibiotics: 
tetracycline 20, ampicillin 20, streptomycin 15, chloramphenicol 25, 
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neomycin 20, and sulfafurazole 200 l'g/ml. After overnight incubation 
each colonial type on each antibiotic-containing plate was subcultured 
and its antibiotic sensitivity was determined by the disc method using 
a standard sensitive Escherichia coli strain as control. E. coli were 
identified as reported previously [10] and serotyped using 150 antisera 
[11] to the somatic ('0') antigens so that individual strains could be 
distinguished. 
RESULTS 
Tetracycline resistance was common in all groups but was 
tnuch higher in patients taking tetracycline and in their rela-
tives than in the other groups (Table I) (p < .01). In these 
tetracycline-taking patients and relatives also, there was a 
general increase in antibiotic resistance (Table II). The differ-
e nces were significant (p < .01) for patients with respect to 
sulfonamide, ampicillin, chloramphenicol, and streptomycin. 
'The differences did not reach significant levels for the relatives 
and although the administration of tetracycline increased the 
Proportion of isolates resistant to the antibiotics tested, it did 
so in such a way as not to change the relative proportions of 
isolates resistant to the different antibiotics. 
The administration of erythromycin did not appear to affect 
antibiotic resistance levels in patients or their relatives (Table 
III) . 
There were a number of instances in which the same strain 
was found in the patient and relatives and these are listed in 
'l'able IV. 
DISCUSSION 
Levels of antibiotic resistance in microorganisms are related 
to antibiotic administration [12,13] and it is well-documented 
that tetracycline given orally will select in the aerobic gut flora 
for resistance not only to tetracycline but also to other anti-
biotics (14). This selection has been demonstrated also in 
patients taking tetracycline for acne, a condition in which a 
low dose may be given for periods of several months. Although 
the major interest has been in levels of antibiotic resistance in 
hospitals, community levels of antibiotic resistance have also 
been noted to be high [7). These high levels can be readily 
related to prescribing habits [7], and the consumption of meat 
from antibiotic-fed animals may be an important source of 
resistant bacteria [12,15). Spread of coliforms between human 
beings is less well documented. Petrocheilou et a] [8) reported 
the isolation of the same strain of E. coli from a patient taking 
tetracycline for acne and from his wife. It is not known whether 
this represents transfer between the two individuals or a com-
lllon source of the organism colonizing them both. 
Although there may be psychological side effects, acne is 
essentially a benign condition and any treatment given for it 
lllust be safe. The administration of antibiotics that have a 
significant effect in selecting for antibiotic resistant organisms 
it~ the community is particularly undesirable in this type of 
disease. When we looked at the bowel flora of our patients 
taking tetracycline we were not surprised to find tetracycline 
and multiply antibiotic-resistant organisms, but the raised lev-
els of tetracycline and multiple antibiotic resistance in the 
relatives of these patients is of importance. It adds to the 
overall pool of antibiotic resistance in the community and, 
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TABLE I. Tetracycline resistance of E. coli i.solated before and during 
treatment 
Patients 
Relatives 
Patients 
Relatives 
T etracycline resistant isola tes 
T etracycline group 
Before treatment 
2/6 (33%) 
3/9 (33%) 
During treatment 
61/61 (100%) 
63/69 (91%) 
Erythromycin group 
5/8 (63% ) 
3/11 (27%) 
19/41 (46%) 
26/60 (43%) 
TABLE II. Antibiotic resistance of E. coli isolated from feces of patients 
and relatives before and during antibiotic therapy 
No. of antibiotics to Before therapy During Therapy 
which resistant Erythromycin group T etracycline group 
Patients 
0 4 (29%) 17 (41%) 0 (0%) 
1 2 (14%) 5 (12%) 6 (10%) 
2 7 (50%) 8 (20%) 22 (36%) 
3 0 (0%) 7 (17%) 11 (18%) 
4 1 (8%) 4 (10%) 12 (20%) 
5 . 0 0 16 (16%) 
14 41 61 
Relatives 
0 12 (55%) 19 (32%) 1 (1%) 
1 3 (15%) 15 (26%) 19 (28%) 
2 2 (10%) 12 (20%) 27 (39%) 
3 1 (5%) 8 (13%) 8 (12%) 
4 1 (5%) 5 (8%) 10 (15%) 
5 0(0%) 0 (0%) 2 (3%) 
6 1 (5%) 1 (2%) 2 (3%) 
20 60 69 
TABLE III. Resistance of E. coli strains isolated from. patients and 
relatives to individual antibiotics 
Antibiotics 
Tetracycline 
Sulfonamide 
Ampicillin 
Chloramphenicol 
Streptomycin 
Neomycin 
No. of strains 
Tetracycline 
Sulfonamide 
Ampicillin 
Chloramphenicol 
Streptomycin 
Neomycin 
No. of strains 
During therapy 
Before therapy -------------
Erythromycin group T etracycline group 
Patients 
7 (50%) 19 (46%) 
9 (63%) 21 (51%) 
1 (7%) 8 (20%) 
0 (0%) 2 (5%) 
3 (21 %) 7(17%) 
0 (0%) 1 (2%) 
14 41 
Relatives 
6 (30%) 26 (43%) 
4 (20%) 32 (43% ) 
2 (10%) 20 (33%) 
2 (10%) 7 (12%) 
3 (15% ) 3 (5%) 
3 (15%) 1 (2%) 
20 60 
61 (100%) 
49 (80%) 
31 (51%) 
16 (26%) 
19 (31 %) 
5 (8%) 
61 
63 (91 %) 
49(71 %) 
20 (20%) 
13 (18%) 
10 (14 %) 
4 (6%) 
69 
although this may not itself predispose to the development of 
infection, if these do occur they may be difficult to treat. The 
mechanism by which antibiotic resistance occurs in the bowel 
t1ora of relatives of antibiotic-taking patients is not clear. The 
concept of transfer of microorganisms between one individual 
and another is not supported by present evidence. In artificial 
feeding experiments in volunteers, 105 organisms need to be 
ingested to be detected in the feces [16] . However, it may be 
that under natural conditions fewer numbers of organisms may 
on occasion implant. A common source of the organisms is a 
possibility. Prepared food purchased for domestic consumption 
regularly contains large numbers of E. coli (A. Pinegar and E. 
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TABLE IV. E. coli isolates of the same serotype and antibiotic 
resistance 
Serotype Antibiotic resista nce Treatment group 
(I) Isolated from patient before or at same time as from a relative 
1 01 T Sui T 
2 086 T Sui A Chlor T 
3 08 T Sui T 
4 09 T Sui T 
5 020 T Sui T 
6 01 Sens E 
7 08 T Sui A Sui E 
(II) Isolated from relative before or at same time as from the patient 
1 08 T Sui T 
2 08 T Sui T (I (3)) 
3 01 T Sui T 
4 020 T Sui T (I (5)) 
(Ill) Isolated from relative before or at same time as another relative 
1 08 T Sui T (I (3) II (1)) 
I (3) II (1) II (2) and III (1) may all represent 1 episode 
Weeks 
1 
2 
3 
Patient 
08 
08 
Relative I 
08 
08 
Relative II 
08 
08 
Key: T = tetracycline, E = erythromycin, Sui = sulfonamide, A = 
ampicillin, Chlor = chloramphenicol, Sens = sensitive. 
M . Cooke, unpublished observations) and some of these are 
multiple antibiotic resistant. The selection present in the pa-
tients taking tetracycline is clear but it is less so in the relatives . 
However, contamination of the environment with tetracycline-
containing skin scales occurs andfl,lthough this will be at low 
levels it may be sufficient to account for these results. Examples 
of the same organism present in different members of the same 
family were more frequent in the tetracycline families than in 
the erythromycin families. A possible although perhaps unlikely 
explanation of this is that tetracycline administration selects 
for strains that are not only resistant but are better able to 
transfer. Alternatively the selection pressure provided by tet-
racycline may apply to the whole family and predispose all to 
colonization with resistant strains from a common source. 
Family studies similar to this one after tetracycline administra-
tion had ceased might provide useful information in attempting 
to elucidate this problem. 
Erythromycin produced no increase in antibiotic resistance 
of the bowel f1ora, this is in keeping with its known range of 
antibacterial activity . These findings give some support for the 
oral use of erythromycin in the treatment of acne . The admin-
istration of tet racycline, however, has important consequences 
not only to the patient but also to the patient's family. It must 
be borne in mind that many patients with acne do require long-
term antibiotic therapy and our patients treated with tetracy-
cline did not suffer clinically recognizable side effects related 
to the changes that had occurred in the gastrointestinal tract. 
The clinical importance of the increase in antibiotic-resistant 
organisms in patients and their relatives during tetracycline 
therapy is difficult to assess and further studies are required. 
However, the possibility of increasing the pool of antibiotic-
resistant organisms in the community must be regarded with 
concern. 
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